Brennan Kevin M.
SEC insider (Form 3/4/5 filer). CIK 0001971303. SVP, FINANCE AND ACCOUNTING at Xilio Therapeutics, Inc. (XLO). 14 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in WALTHAM, MA.
Companies Brennan Kevin M. has filed insider reports for
- Xilio Therapeutics, Inc. (XLO): Officer, SVP, FINANCE AND ACCOUNTING
Brennan Kevin M.
CIK: 0001971303
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Xilio Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jan 2, 2026XLO
Xilio Therapeutics, Inc.
SaleDirect1.8K shares at avg. $0.64$1K - Jan 1, 2026XLO
Xilio Therapeutics, Inc.
ExerciseDirect5K shares- - Dec 31, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
95.2K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
55K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
25K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
25K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
20K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
20K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
131.7K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
55K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | XLO Xilio Therapeutics, Inc. | Sale | 1,826 | $0.64 | $1,174 | Direct |
| Jan 1, 2026 | XLO Xilio Therapeutics, Inc. | Exercise | 5,000 | - | $0 | Direct |
| Dec 31, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 95,221 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 55,000 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Disposition Stock Option (right to buy) | 25,000 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 25,000 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Disposition Stock Option (right to buy) | 20,000 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 20,000 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 131,700 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Disposition Stock Option (right to buy) | 55,000 | - | - | Direct |
1-10 of 14 transactions